152 related articles for article (PubMed ID: 28448232)
1. Dynamic Contrast-enhanced MR Imaging Parameters in Bone Metastases from Non-Small Cell Lung Cancer: Comparison between Lesions with and Lesions without Epidermal Growth Factor Receptor Mutation in Primary Lung Cancer.
Kim HS; Yoon YC; Kwon S; Lee JH; Ahn S; Ahn HS
Radiology; 2017 Sep; 284(3):815-823. PubMed ID: 28448232
[TBL] [Abstract][Full Text] [Related]
2. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
3. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
[TBL] [Abstract][Full Text] [Related]
4. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors.
Joo I; Lee JM; Han JK; Yang HK; Lee HJ; Choi BI
J Magn Reson Imaging; 2015 Jun; 41(6):1608-14. PubMed ID: 25044978
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
Choi YS; Park M; Kwon HJ; Koh YW; Lee SK; Kim J
AJR Am J Roentgenol; 2016 Feb; 206(2):408-13. PubMed ID: 26797372
[TBL] [Abstract][Full Text] [Related]
7. A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases.
Chen YM; Fang YT; Lai CH; Rau KM; Huang CH; Chang HC; Chao TY; Tseng CC; Fang WF; Wang CC; Chen YC; Chung YH; Wang YH; Su MC; Liu SF; Huang KT; Chen HC; Chang YC; Chang YP; Lin MC
PLoS One; 2016; 11(12):e0167923. PubMed ID: 27930702
[TBL] [Abstract][Full Text] [Related]
8. A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females.
Zhang X; Pang H; Dong Y; Shi D; Liu F; Luo Y; Yu T; Wang X
Osteoporos Int; 2019 Dec; 30(12):2469-2476. PubMed ID: 31451839
[TBL] [Abstract][Full Text] [Related]
9. Correlation of MRI quantitative perfusion parameters with EGFR, VEGF and EGFR gene mutations in non-small cell cancer.
Zou M; Zhang B; Shi L; Mao H; Huang Y; Zhao Z
Sci Rep; 2024 Feb; 14(1):4447. PubMed ID: 38396128
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Continued Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Administration in EGFR-mutated Non-Small Cell Lung Cancer with Skeletal Metastasis.
Hong SH; Kim YS; Lee JE; Kim IH; Kim SJ; Han D; Yoo IeR; Chung YG; Kim YH; Lee KY; Kang JH
Cancer Res Treat; 2016 Jul; 48(3):1110-9. PubMed ID: 26790969
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
[TBL] [Abstract][Full Text] [Related]
12. Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer.
Huang YS; Chen JL; Chen HM; Yeh LH; Shih JY; Yen RF; Chang YC
BMC Cancer; 2021 Apr; 21(1):348. PubMed ID: 33794813
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
[TBL] [Abstract][Full Text] [Related]
14. EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?
Hendriks LE; Smit EF; Vosse BA; Mellema WW; Heideman DA; Bootsma GP; Westenend M; Pitz C; de Vries GJ; Houben R; Grünberg K; Bendek M; Speel EJ; Dingemans AM
Lung Cancer; 2014 Apr; 84(1):86-91. PubMed ID: 24529684
[TBL] [Abstract][Full Text] [Related]
15. EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan.
Guan J; Chen M; Xiao N; Li L; Zhang Y; Li Q; Yang M; Liu L; Chen L
Med Oncol; 2016 Jan; 33(1):1. PubMed ID: 26589606
[TBL] [Abstract][Full Text] [Related]
16. Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors.
Chen YM; Lai CH; Rau KM; Huang CH; Chang HC; Chao TY; Tseng CC; Fang WF; Chen YC; Chung YH; Wang YH; Su MC; Huang KT; Liu SF; Chen HC; Chang YC; Chang YP; Wang CC; Lin MC
Lung Cancer; 2016 Aug; 98():99-105. PubMed ID: 27393514
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor mutations should be considered as a prognostic factor for survival of patients with pathological fractures or painful bone metastases from non-small cell lung cancer.
Willeumier JJ; van der Hoeven NM; Bollen L; Willems LN; Fiocco M; van der Linden YM; Dijkstra PD
Bone Joint J; 2017 Apr; 99-B(4):516-521. PubMed ID: 28385942
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
Oh E; Yoon YC; Kim JH; Kim K
Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of epidermal growth factor receptor and KRAS gene status between primary and corresponding metastatic tumours of non-small cell lung cancer.
Wang S; Wang Z
Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):30-9. PubMed ID: 25445553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
